Clin2
NCT01964859Possibly a fitRecruiting

Testing your own skin cells to heal skin

Wounds and Injuries

Part of Injuries & trauma clinical trials.

This study checks whether a treatment using your own skin graft material is safe and feasible. It aims to see if using a small sample from your skin and making an “autologous” skin graft can be done safely and with good follow-through.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You’re between 18 and 65 years old
  • You can understand the consent form and agree to participate
  • You must have healthy skin where the study will take samples
  • If you can become pregnant: your pregnancy test must be negative, and you must avoid pregnancy and breastfeeding during the study and for 1 month after
  • You must be able to return for all visits and follow wound care and skin procedures
  • You cannot have received any other investigational (study) medicine in the last 30 days

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04079348Recruiting
Pig-based wound dressing study for skin graft donor sites

This study tests how well a pig-based covering dressing works on skin graft donor-site wounds (where skin is taken to make a graft). It may help support faster, safer healing after a split-thickness skin graft.

Manchester, England
NCT03947450Recruiting· Phase 2
Injection of your own skin cells into below-knee amputation site

This Phase 2 study tests whether injecting a patient’s own fibroblast cells (skin-support cells) into the wound area after a below-knee amputation can help the stump skin heal and work better. It’s intended for people who already have (or are close to having) a prosthetic fitting.

Baltimore, Maryland
NCT04839497Recruiting· Phase 2
Safety and benefit of injecting fibroblast cells in leg amputees’ skin

This Phase 2 study tests whether injecting a patient’s own (autologous) fibroblast cells into the end of a transtibial (below-knee) amputation is safe and may improve outcomes. You may qualify if you have a certain type of prosthesis timing and healthy skin on the stump, and you can follow frequent visit and wound-care instructions.

Baltimore, Maryland
NCT07562230Recruiting
Tissue-engineered skin to repair difficult wounds

This trial tests a lab-grown skin product designed to help heal stubborn wounds that won't close on their own—including burns, diabetic foot ulcers, and pressure sores. The goal is to see if this engineered skin can speed up healing and reduce scarring.

Guangzhou, Guangdong
NCT05882110Recruiting
Growing your own skin cells to heal large deep wounds

This trial tests a way to grow your own skin cells to help heal very large, deep wounds that are expected to take at least 2 weeks to heal. It may be most helpful if you have a major skin injury covering a large part of your body.

Shanghai, Shanghai Municipality
NCT07551284Not yet recruiting
Basement Membrane Regeneration for Wound Repair

This trial tests a new approach to help wounds heal better by regenerating basement membrane, a natural layer under the skin. It may help people with burns, surgical wounds, diabetic ulcers, pressure sores, and other difficult-to-heal wounds recover with better scarring and function.

Hear when a new Wounds and Injuries trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.